PDF Cover

Endoscopic Ultrasound Market

The market for Endoscopic Ultrasound was estimated at $1.7 billion in 2025; it is anticipated to increase to $2.5 billion by 2030, with projections indicating growth to around $3.5 billion by 2035.

Report ID:DS1801221
Author:Debadatta Patel - Senior Consultant
Published Date:
Datatree
Life Science
Medical Device
Endoscopic Ultrasound
Share
Report Summary
Market Data
Methodology
Table of Contents

Global Endoscopic Ultrasound Market Outlook

Revenue, 2025

$1.7B

Forecast, 2035

$3.5B

CAGR, 2026 - 2035

7.3%

The Endoscopic Ultrasound industry revenue is expected to be around $1.9 billion in 2026 and expected to showcase growth with 7.3% CAGR between 2026 and 2035. Precision gastroenterology is viewed as a major focus region for endoscopic ultrasound, the future of which looks rosy due to a growing incidence of the diseases, a rise in screening programmes and technology improvements in endoscopy departments and outpatient clinics alike including EUS interventions. Among the various applications of endoscopic ultrasound, pancreaticobiliary disease and gastrointestinal cancer are involved in 66.5% of cases, making the technique fundamental in the gastrointestinal cancer diagnosis and treatment. It aids in the early diagnosis and the treatment planning, as well as the staging of gastrointestinal cancer. Portable endoscopic ultrasound equipment is experiencing a surge in adoption, accounting for $1.32 billion in sales in the year 2025. This has contributed to its impact on medical care at the point of treatment by facilitating quicker and more efficient procedures in hospitals. As a result of this increased adoption, there are noticeable improvements in the efficiency of gastrointestinal endoscopy clinics and patient flow. In line with a shift towards non invasive diagnostics where imaging is done in real time, Endoscopic Ultrasound is vital for healthcare professionals as they make evidence based decisions and provide care of high value.

Using endoscopic ultrasound we obtain cross sectional images of the bodys organs such as the digestive tract. This is achieved by using endoscopes with high frequency ultrasound built into the end of them. The images produced are of high definition. The systems features include high resolution endoscopic ultrasound imaging, the capability to penetrate deep into body tissues and characterise lesions accurately and the facility to guide a fine needle aspiration or biopsy. It has applications in the evaluation of pancreaticobiliary disorders, the staging of oesophageal, gastric, and rectal cancers, the assessment of gastric subepithelial lesions, the drainage of pancreatic abscesses and fluid collections and the identification of small tumours, for instance. The growing demand for portable ultrasound systems is being driven by several factors including increased availability of compact products, the integration of image enhancement tools and automation of workflow, and the increased use of endoscopic ultrasound at cancer treatment centres and specialist interventional units.

Endoscopic Ultrasound market outlook with forecast trends, drivers, opportunities, supply chain, and competition 2025-2035
Endoscopic Ultrasound Market Outlook

Market Key Insights

  • The Endoscopic Ultrasound market is projected to grow from $1.7 billion in 2025 to $3.5 billion in 2035. This represents a CAGR of 7.3%, reflecting rising demand across Diagnosis & Staging of Cancer, Chronic Pancreatitis Investigation, and Interventional Endoscopy.

  • The medical ultrasonic market can be classed as oligopolistic with just 7 firms dominant, with the key firms being Olympus Corporation and Boston Scientific Corporation.

  • The markets for endoscopic ultrasound in both the US and Japan are leading globally and are predicted to show a growth rate of 4.7 7.0% by the years 2025 and 2030.

  • The countries with the highest growth expectations are the emerging markets of India, Brazil and South Africa with 8.4% to 10.1% CAGR.

  • The endoscopic ultrasound sector is becoming increasingly attractive to investors due to the emergence of cutting edge technology. These modifications are anticipated to create a positive cycle which supports growth and adds a value of approximately $0 million between 2026 and 2030.

  • Between 2025 and 2035, the market for endoscopic ultrasound will increase by $1.8 billion. It is anticipated that the share of pancreaticobiliary disease as well as small mural lesion applications by manufacturers will increase.

  • As endoscopic ultrasound procedures continue to advance, and the number of people suffering from chronic diseases rises, it is anticipated that the market for endoscopic ultrasound will rise by 102% over the period from 2025 to 2035.

endoscopic ultrasound market size with pie charts of major and emerging country share, CAGR, trends for 2025 and 2032
Endoscopic Ultrasound - Country Share Analysis

Opportunities in the Endoscopic Ultrasound

In the United States and Europe, many hospitals use Endoscopic Ultrasound to find cancer and help treat cancer. More doctors now use endoscopes for cancer staging, EUS guided celiac plexus neurolysis, and for giving medicine exactly where it is also needed. Because of this, more people need high performance endoscopes. Endoscopes now make about $1.32 billion across the world. Experts think endoscopes could bring in $1.81 billion by 2030. The endoscopes market may grow by 6.5% each year. Doctors will do more interventional EUS procedures for pancreatic cancer, esophageal cancer, and lung cancer. The number of these procedures will grow fastest in comprehensive cancer centers and in places where care teams work together.

Growth Opportunities in North America and Asia-Pacific

The high prevalence of pancreatic cancer in North America has led to the rapid adoption of the Endoscopic Ultrasound. North America's financially stable healthcare system also offers strong reimbursement for diagnostic procedures like this one. EUS has also been a big help in the treatment of gastrointestinal cancer. This medical technique is most commonly used to help diagnose diseases of the pancreas and the bile duct. Currently, in the field of endoscopic ultrasound, there are many existing equipment models competing on the basis of image quality, integration with endoscopy systems and staff training for procedures. The biggest market opportunities arise from hospitals updating their existing equipment to endoscopic ultrasound devices with more advanced imaging and in the expansion of sales to out patient clinics and community hospitals. Emphasis should be placed on implementing premium platforms for EUS guided therapies, analytics driven reporting tools which support multidisciplinary cancer treatment and flexible service contracts that combine software maintenance training to support customer loyalty and clinical outcomes.
Gastrointestinal cancer is driving the use of endoscopic ultrasound in Asia Pacific, largely due to growing incidence and awareness of minimally invasive diagnostic procedures. Pancreatic and biliary diseases are also experiencing significant growth in this region. Tertiary care facilities are being expanded, further increasing demand for endoscopic ultrasound procedures. Demand for SML evaluation is also on the rise in this region. In this sector, both large multinationals and local firms are competing, thus dividing the market into various groups. It is in these diverse sections of the market that Endoscopic Ultrasound systems of value, along with cost effective supplies and the in house clinical instruction, can differentiate the products of the firm from its competitors. This helps to ensure hospitals which conduct endoscopies on a large scale can afford these goods. By placing operations in the region, companies can capitalise on opportunities. This strategy involves making products and service networks based in the region. The company should produce products that can be used in a variety of different situations such as in cancer diagnosis, in the inspection of the pancreas and bile ducts and in characterising small cell lesions.

Market Dynamics and Supply Chain

01

Driver: Growing incidence of gastrointestinal cancers and rising demand for minimally invasive diagnostic procedures

One of the foremost drivers for the endoscopic ultrasound market is also the increasing global incidence of gastrointestinal cancers, including pancreatic, esophageal, and colorectal cancers. As these cancers become more prevalent, there is also greater clinical demand for precise diagnostic and staging tools that can also accurately assess tumor depth, lymph node involvement, and metastatic spread. Endoscopic ultrasound provides high resolution imaging of the gut wall and adjacent structures, enabling early detection and targeted biopsy. Simultaneously, the broader trend toward minimally invasive diagnostics is also pushing clinicians away from traditional surgical exploration and imaging techniques that offer lower tissue resolution. EUS meets this need by combining endoscopy and ultrasound into a single procedure, allowing tissue sampling without surgical intervention. These factors together are also expanding utilization across oncology centers, gastrointestinal clinics, and specialized hospitals, supporting broader adoption and revenue growth for advanced EUS systems worldwide.
Another significant driver is also the integration of cutting edge imaging technologies such as contrast enhanced endoscopic ultrasound, elastography, and AI assisted lesion characterization within EUS systems. These advancements are also enhancing the diagnostic clarity and clinical utility of endoscopic ultrasound by improving tissue differentiation, real time visualization, and lesion targeting during biopsy. Artificial intelligence and machine learning algorithms help reduce operator dependency, improve interpretation consistency, and support faster decision making during complex procedures. This trend is also encouraging adoption among gastroenterologists, oncologists, and interventional endoscopy specialists as it elevates the accuracy and confidence of diagnostic outcomes, creating new opportunities for expanded clinical use and competitive differentiation among EUS device manufacturers.
02

Restraint: High equipment costs and limited availability in resource constrained healthcare settings

A key restraint for endoscopic ultrasound market growth is the high upfront cost of advanced EUS systems and related maintenance expenses. Many healthcare facilities, especially in developing regions and smaller clinics, struggle to invest in premium ultrasound endoscopes, high resolution processors, and dedicated accessories. This cost barrier limits procurement, slows adoption, and often confines EUS services to tertiary care centers. For example, rural hospitals may continue relying on conventional imaging due to budget limitations, reducing overall demand and slowing revenue growth for manufacturers targeting broader market penetration beyond major metropolitan hospitals.
03

Opportunity: Unmet need for cost-efficient Endoscopic Ultrasound systems in public healthcare networks throughout Latin America and Accelerating adoption of Endoscopic Ultrasound for pancreatic cancer diagnosis in rapidly expanding Asia-Pacific gastroenterology centers

Across Latin America the availability of endoscopic ultrasounds in public healthcare networks is low and there is a rise in gastrointestinal cancer incidence. Healthcare facilities with limited financial resources are looking for cost effective medical equipment solutions; this may be found through the use of systems which combine new ultrasound probes with refurbished endoscopes and ultrasonic processors. By forming alliances with government agencies and private health insurance companies, healthcare providers can obtain discounts through bulk purchasing contracts and also have access to low cost educational programs. There will be rapid increases in the number of endoscopic ultrasounds used in Brazil, Mexico and Colombia. Here the greatest expansion will be in basic tests which diagnose conditions, and this will be largely due to new screening initiatives that are being introduced in the region.
The growing burden of pancreatic and biliary diseases in the Asia Pacific region has led to an increase in the demand for the use of endoscopic ultrasounds within specialist gastroenterology units. Healthcare facilities are increasingly turning to minimally invasive diagnostic techniques which employ advanced ultrasound probes and curved linear array endoscopes. Worldwide ultrasound probes have a current revenue of $0.41 billion and are forecast to expand to $0.65 billion by the year 2030 at a compound annual growth rate of 9.71%. They will be the medical imaging device sector to grow most quickly, mainly due to endoscopic ultrasound guided fine needle biopsy and improvement in gastroenterology imaging. Key markets will be in China, India and SE Asia.
04

Challenge: Need for specialized training and steep learning curve for endoscopic ultrasound procedures

Another major constraint is the requirement for extensive clinician training and proficiency to perform and interpret EUS examinations effectively. Endoscopic ultrasound procedures demand a high level of technical skill, hand eye coordination, and experience in ultrasound image interpretation. Hospitals and ambulatory centers may face delays in service implementation due to limited trained personnel, impacting procedure volumes and slowing adoption. For instance, clinicians without structured training programs may prefer alternative diagnostic tools, which reduces procedure frequency and affects market dynamics by restricting growth to centers with established endoscopic expertise.

Supply Chain Landscape

1

Minimally Invasive Components

Hitachi HealthcareAnalogic CorporationTE Connectivity
2

Endoscopic Ultrasound Production

Olympus Corp.Boston Scientific Corp.FUJIFILM India Pvt. Ltd
3

Endoscopic Ultrasound Logistics

Cardinal HealthMedline IndustriesHenry Schein
4

Clinical Applications

HospitalsGastroenterology ClinicsDiagnostic Imaging Centers
Endoscopic Ultrasound - Supply Chain

Use Cases of Endoscopic Ultrasound in Diagnosis & Staging of Cancer & Interventional Endoscopy

Diagnosis & Staging of Cancer : In oncology practice, endoscopic ultrasound plays a critical role in the diagnosis and staging of gastrointestinal, pancreatic, and lung cancers. Linear array endoscopic ultrasound systems are most commonly used in this application because they allow real time imaging combined with fine needle aspiration or biopsy. Oncologists and gastroenterologists rely on these systems to assess tumor depth, lymph node involvement, and vascular invasion with high precision. The ability to obtain tissue samples during the same procedure improves diagnostic accuracy and reduces the need for exploratory surgery. This approach enhances early detection, supports personalized treatment planning, and improves overall staging efficiency in specialized cancer care centers.
Chronic Pancreatitis Investigation : For chronic pancreatitis investigation, radial endoscopic ultrasound systems are frequently utilized to provide detailed cross sectional imaging of pancreatic parenchyma and ductal structures. Gastroenterologists use this modality to detect early fibrotic changes, calcifications, and duct irregularities that may not be visible on conventional imaging. The high resolution imaging capability of endoscopic ultrasound enables accurate differentiation between inflammatory conditions and malignant lesions. Its minimally invasive nature allows repeated evaluations for disease monitoring without significant patient discomfort. This application is particularly valuable in tertiary hospitals and advanced gastroenterology clinics, where precise assessment of pancreatic abnormalities guides long term management and therapeutic decisions.
Interventional Endoscopy : In interventional endoscopy, linear endoscopic ultrasound systems are predominantly employed to guide therapeutic procedures such as cyst drainage, celiac plexus neurolysis, biliary access, and tumor ablation. These systems provide real time needle guidance, allowing clinicians to perform targeted interventions with enhanced safety and precision. Endoscopic ultrasound guided therapies reduce the need for open surgical procedures and shorten recovery times. Interventional endoscopists in specialized centers benefit from improved visualization of surrounding vessels and organs, minimizing procedural complications. This application continues to expand as advanced accessories and therapeutic tools integrate with ultrasound platforms, driving the evolution of minimally invasive gastrointestinal interventions.

Recent Developments

Recent developments in the endoscopic ultrasound market reflect a strategic shift toward high-resolution imaging, AI-assisted diagnostics, and minimally invasive therapeutic integration. Leading manufacturers are focusing on advanced EUS systems with elastography, contrast-enhanced imaging, and fine needle aspiration compatibility, strengthening clinical adoption in oncology and pancreatic disease management. Partnerships between device makers and hospitals are accelerating upgrades to linear echoendoscopes and ultrasound processors. A key trend is the integration of AI-driven image analysis and interventional endoscopy tools, enhancing diagnostic accuracy, workflow efficiency, and demand for next-generation endoscopic ultrasound platforms in tertiary care centers.

January 2024 : Olympus Corporation and Canon Medical Systems Corporation entered into a strategic collaboration in January 2024 to co-develop and commercialize advanced endoscopic ultrasound (EUS) systems. Under this alliance Canon Medical will develop and manufacture diagnostic ultrasound components used in EUS, while Olympus will handle global sales and marketing, aiming to enhance imaging performance and expand the technology’s reach in markets such as Japan and Europe.
September 2024 : Boston Scientific Corporation obtained FDA 510(k) clearance in September 2024 for its AXIOS electrocautery-enhanced delivery system, designed to support endoscopic ultrasound-guided drainage procedures such as pancreatic pseudocyst and biliary obstruction treatment. This approval expands therapeutic applications of EUS technology and enhances minimally invasive intervention options.

Impact of Industry Transitions on the Endoscopic Ultrasound Market

As a core segment of the Medical Device industry, the Endoscopic Ultrasound market develops in line with broader industry shifts. Over recent years, transitions such as The Advent of Technological Enhancements and The Integration of AI have redefined priorities across the Medical Device sector, influencing how the Endoscopic Ultrasound market evolves in terms of demand, applications and competitive dynamics. These transitions highlight the structural changes shaping long-term growth opportunities.
01

The Advent of Technological Enhancements

Advances in endoscopic ultrasound technology have helped the sector to evolve from an region purely of clinical interest into a promising investment opportunity. Key improvements include digital imaging and enhanced probe design. As a result, diagnostic procedures can be made more accurate without needing invasive operations. Advances in imaging enable a more accurate diagnosis of gastrointestinal problems and staging of cancer through less invasive procedures. This leads to a range of benefits including improved patient outcomes and a more efficient workflow. Hospitals are also more likely to receive reimbursement for treatments and are more likely to adopt these procedures. The clinical performance of the endoscopic ultrasound will be enhanced by these developments, a point in line with what both payers and providers are hoping for. The sector is expected to experience significant growth as a result, generating an extra $92 million by 2030, and giving businesses the premium differentiation and long term competitive edge they need.
02

The Integration of AI

With the increasing industrial use of AI, researchers have found endoscopic ultrasound to be used with considerable benefits. Clinical staff can also rely on the aid of computers to more accurately and quicker read medical images. The application of ML algorithms not only raises the quality of the images but it also cuts the number of misinterpretations of the images significantly. The integration of this technology marks the beginning of a period in which clinical diagnosis is characterized by both speed and precision. This results in improved patient satisfaction as well as faster service delivery.